The gene mutation of GPX4 did occur in certain cancers, such as SARC, ACC, Glioma, miscellaneous neuroepithelial tumors, and CHOL, OV and CESC, but the proportion of such gene mutations was no more than 8%. This evidence concerns the gene GPX4 and central nervous system cancer.